Metraipolis › archive › dc_0c110ee04414
KEAP1 mutations activate the NRF2 pathway to drive cell growth and migration, and attenuate drug response in thyroid cancer — Europe PMC PMID:41573641
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41573641
- DOI
- 10.3389/fonc.2025.1685379
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:58:29.837Z
- SHA-256 of the archived text
0f101a5d4a21daf8c75782fabb7adf97db2ad3c7da84fcfad020bcbef73e21ea- Stable URL of this page
https://metraipolis.com/documento/dc_0c110ee04414
How to cite
KEAP1 mutations activate the NRF2 pathway to drive cell growth and migration, and attenuate drug response in thyroid cancer — Europe PMC PMID:41573641 — Europe PMC (en), https://europepmc.org/article/MED/41573641 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0c110ee04414 (Metraipolis archive dc_0c110ee04414, sha256 0f101a5d4a21daf8c75782fabb7adf97db2ad3c7da84fcfad020bcbef73e21ea)
BibTeX
@misc{dc0c110ee04414,
title = {KEAP1 mutations activate the NRF2 pathway to drive cell growth and migration, and attenuate drug response in thyroid cancer — Europe PMC PMID:41573641},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41573641},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0c110ee04414; sha256 0f101a5d4a21daf8c75782fabb7adf97db2ad3c7da84fcfad020bcbef73e21ea},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41573641. Agents can read the archived copy with the MCP tool read_document.